Therapeutic modalities for the prevention of nephrolithiasis.
D000818:Animals; D001581:Benzothiadiazines; D004044:Dietary Proteins / Q000009:adverse effects; D004232:Diuretics; D004326:Drinking; D006801:Humans; D007669:Kidney Calculi / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D001581:Benzothiadiazines; D004044:Dietary Proteins; D004232:Diuretics; D010710:Phosphates; D049993:Sodium Chloride Symporter Inhibitors; D008276:Magnesium Hydroxide